06 November 2020 – Fourth round of seroprevalence study begins

Type of Intervention: Specific Action
Sectors Involved: Health, Research and Development
Level of Jurisdiction: National
Lead People/Agency: Ministry of Health and Ministry of Science and Innovation

Overview: Fourth round of national ENE-COVID seroprevalence study begins

The ENE-COVID study is a sero-epidemiological investigation that began last April and that seeks to provide estimates of the prevalence of infection by SAS-CoV-2, present or past, to increase knowledge about the evolution of the pandemic.
This fourth round of national ENE-COVID seroprevalence study is coordinated by the Ministry of Health and the Ministry of Science and Innovation through the Carlos III Health Institute (ISCIII), and is the only one in the world that allows calculating with very high rates of rigor and precision data on the percentage of infections on a population scale.
The completion of this fourth round was agreed by the autonomous communities within the Interterritorial Council of the National Health System on September 9.
The study will serve to boost research on the duration of antibodies in people who were infected in the first wave of the epidemic.

Full details here: https://www.ciencia.gob.es/portal/site/MICINN/menuitem.edc7f2029a2be27d7010721001432ea0/?vgnextoid=8c9be0ae22d95710VgnVCM1000001d04140aRCRD&vgnextchannel=c7fd8357ad4cb210VgnVCM1000001a04140aRCRD

Other links: 1
Type of Justification: Advice of INTERNAL government advisory committee or group, Scientific Evidence (e.g. academic paper, report)
Source of Evidence or Justification: National – academic, National – government